IL15 and neoplasm: Moreover, previous studies have reported that IL15 superagonist-stimulated NK cells enhance in vivo antitumor efficacy by promoting tumor infiltration [30], and IL15-expanded KLRG1+ NK cells protect mice from pulmonary metastatic colorectal carcinoma [10].